You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 19, 2026

dextrose; potassium chloride; sodium chloride - Profile


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for dextrose; potassium chloride; sodium chloride and what is the scope of freedom to operate?

Dextrose; potassium chloride; sodium chloride is the generic ingredient in one hundred and thirteen branded drugs marketed by B Braun, Baxter Hlthcare, Fresenius Kabi Usa, Otsuka Icu Medcl, and Icu Medical Inc, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

Summary for dextrose; potassium chloride; sodium chloride
US Patents:0
Tradenames:113
Applicants:5
NDAs:13

US Patents and Regulatory Information for dextrose; potassium chloride; sodium chloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.075% dextrose; potassium chloride; sodium chloride INJECTABLE;INJECTION 018268-009 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
B Braun DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER dextrose; potassium chloride; sodium chloride INJECTABLE;INJECTION 018268-004 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
B Braun DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.224% IN PLASTIC CONTAINER dextrose; potassium chloride; sodium chloride INJECTABLE;INJECTION 018268-005 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Dextrose; potassium chloride; sodium chloride Market Analysis and Financial Projection

Last updated: February 3, 2026

What Are the Market Fundamentals for Dextrose, Potassium Chloride, and Sodium Chloride?

Dextrose, potassium chloride (KCl), and sodium chloride (NaCl) are widely used pharmaceuticals and food additives, with markets characterized by volume-driven demand, stable raw material supplies, and regulatory oversight. Their roles vary across medical, nutritional, and industrial applications, influencing market dynamics.

Market Size and Demand Drivers

  • Dextrose (Glucose):
    Used in intravenous (IV) solutions, glucose supplements, and as a component in enteral nutrition. The global IV fluids market was valued at about $12 billion in 2021, with dextrose constituting a major part. Growth driven by aging populations, increasing hospitalizations, and rising diabetes prevalence.

  • Potassium Chloride:
    Primarily used for electrolyte replenishment in medical settings. The global KCl market was estimated at ~$2.5 billion in 2022, growing annually around 5% due to rising chronic kidney disease and electrolyte imbalance cases.

  • Sodium Chloride:
    Applied in saline solutions, dialysis, and as a raw material in chemical processes. The global NaCl market was valued at approximately $3.8 billion in 2022, with steady growth aligned with healthcare, industrial, and food sectors.

Supply Chain and Raw Material Considerations

All three compounds are derived from natural sources or synthesized through industrial processes:

  • Dextrose: Produced via glucose fermentation of starches (corn, wheat, or cassava). Supply chain is robust, with major producers in North America, Europe, and Asia.

  • Potassium Chloride: Extracted mainly from underground mineral deposits (e.g., potash ores) or produced via solution mining. The largest producers include Canada, Russia, and Belarus.

  • Sodium Chloride: Mined from salt deposits or obtained through seawater evaporation. Countries like China, the US, and Germany dominate production.

Raw material availability ensures stable supply; however, geopolitical tensions and environmental regulations influence pricing and supply chain risk.

Pricing Trends and Competitive Landscape

Pricing stability varies:

  • Dextrose prices fluctuated within a narrow band historically but faced upward pressure recently due to increased demand for hospital supplies.

  • Potassium chloride prices have experienced volatility driven by supply chain disruptions, weather, and fertilizer demand. Spot prices ranged from $250 to $350 per ton in 2022.

  • Sodium chloride remains relatively low cost; however, purification and specialty-grade NaCl for pharmaceutical use command premiums exceeding industrial grades by 50-100%.

Major players include Fresenius Kabi, Baxter, and local generic manufacturers, with market entry barriers tied to manufacturing standards and regulatory approval.

Regulatory Environment and Market Access

Approval processes are critical for pharmaceutical-grade products, requiring compliance with Good Manufacturing Practices (GMP) and quality standards set by agencies like the FDA and EMA.

Intellectual property rights are limited given the nature of these inorganic compounds. However, formulations and manufacturing processes may be patented, influencing competitive positioning.

What Are the Key Investment Considerations?

Market Growth and Revenue Opportunities

  • Growing use in biological and hospitalization settings supports steady demand.
  • Development of specialty formulations (e.g., buffered solutions, additive blends) presents niche opportunities.
  • Market expansion into emerging countries driven by healthcare infrastructure growth.

Risks and Challenges

  • Price fluctuations linked to raw material costs and geopolitical risks.
  • Regulatory compliance requirements increase manufacturing costs.
  • Competition from regional producers and low-cost imports pressure margins.

Investment Outlook

Steady volume-driven markets with moderate growth potential. Companies with integrated supply chains, GMP-certified manufacturing, and product diversification are positioned for stable returns. Focus on innovations in formulation or specialty applications can provide additional growth leverage.

What Are the Competitive and Regulatory Factors?

Factor Impact Considerations
Supply security Reduces operational risk Vertical integration or diversified sourcing mitigates supply disruptions
Regulatory compliance Ensures market access Investment in GMP certifications is essential
Pricing dynamics Affects margins Monitor raw material costs and spot market prices
Innovation Drives differentiation Develop specialized formulations or delivery systems

What Are the Key Takeaways?

  • These inorganic salts have stable demand across medical, nutritional, and industrial sectors.
  • Market growth is driven by healthcare needs, aging populations, and expanding emerging markets.
  • Raw material availability is generally stable but subject to geopolitical and environmental factors.
  • Price volatility exists but remains within manageable bounds for established players.
  • Regulatory compliance and product quality are critical for market access.

FAQs

1. How does raw material cost impact the profitability of these compounds?
Raw material costs influence manufacturing expenses; fluctuations can impact margins, especially for lower-margin industrial-grade products. Pharmaceutical-grade products typically command higher prices, mitigating some raw material cost effects.

2. Are there opportunities for new entrants in these markets?
Entry barriers include high regulatory standards, established global suppliers, and certification requirements. However, niche applications like specialty formulations afford opportunities for differentiation.

3. What factors could disrupt supply chains for these compounds?
Geopolitical tensions, resource scarcity, natural disasters affecting mining or production facilities, and regulatory changes can impair supply continuity.

4. How does demand in emerging markets influence the global outlook?
Expanding healthcare infrastructure, increased disease prevalence, and rising investment in pharmaceuticals in Asia, Africa, and Latin America contribute to growth prospects.

5. What role do innovations in formulation play in market expansion?
Developing new delivery forms, combining compounds with other active ingredients, and improving stability can open new market segments and improve margins.


Sources:
[1] MarketsandMarkets. "IV fluids market," 2021
[2] Grand View Research. "Potassium Chloride Market," 2022
[3] Research and Markets. "Sodium Chloride Market," 2022

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.